Cancer biology

Cancer Biology division strives on the interdisciplinary research that translates the new findings into developing of angiogenesis inhibitors, early detection/therapeutics using cancer stem cells and gene editing, omics technology, radio-sensitizing agents, biosensors and genetic screening including epigenetics of cell cycle regulation and xenograft models for personalized medicine.

 

Understanding the molecular mechanisms of development and progression of triple-negative Breast/Cervical/Gastric/Head & Neck cancer. Manipulation of c-MPL splicing in myeloid leukemia, evaluation of incidence for BRCA1 mutation in women, revealing the drug action in the tumor microenvironment, adjuvant treatment development for glioma by a combination of gamma radiation and angiogenesis inhibition, immune-modulation in lung cancer.

 

Faculty Members